Blog
RSS FeedPosted by Michael Wonder on 23 Sep 2019
NICE seeks feedback from users of the evidence standards framework for digital health technologies
23 September 2019 - Consultation on priority areas open to stakeholders until mid October. ...
Posted by Michael Wonder on 18 Apr 2018
The use of MCDA in HTA: great potential, but more effort needed
18 April 2018 - The potential for multi-criteria decision analysis (MCDA) to support health technology assessment (HTA) has been much discussed, ...
Posted by Michael Wonder on 13 Apr 2018
Decision components of NICE's technology appraisals assessment framework
10 April 2018 - The UK's NICE is an established health technology assessment agency. de Folter et al. present a ...
Posted by Michael Wonder on 16 Oct 2017
Social value and individual choice: the value of a choice-based decision-making process in a collectively funded health system
4 October 2017 - Evidence about cost-effectiveness is increasingly being used to inform decisions about the funding of new technologies that ...
Posted by Michael Wonder on 09 Oct 2017
Time for a change in how new antibiotics are reimbursed: development of an insurance framework for funding new antibiotics based on a policy of risk mitigation
9 October 2017 - Healthcare systems depend on the availability of new antibiotics. ...
Posted by Michael Wonder on 27 Sep 2017
New advance value framework offered as a decision-support tool for reimbursement
25 September 2017 - Researchers at the London School of Economics and Political Science have developed a multiple criteria decision ...
Posted by Michael Wonder on 28 Aug 2017
How to design the cost-effectiveness appraisal process of new health care technologies to maximise population health: a conceptual framework
22 August 2017 - This paper presents a conceptual framework to analyse the design of the cost-effectiveness appraisal process of new ...
Posted by Michael Wonder on 11 Oct 2016
Cost, effectiveness, and value. How to judge?
11 October 2016 - Former NICE Chairman Sir Michael Rawlins offers his views in JAMA. ...